<DOC>
	<DOCNO>NCT01988376</DOCNO>
	<brief_summary>Background/Purpose : This large scale , multicenter randomize clinical trial ass feasibility use SurePath® cervical cancer patient radiation therapy compare incidence unsatisfactory smear accuracy detect cervicovaginal lesion SurePath® conventional smear . Patients Methods : The investigator invite woman receive radiotherapy cervical cancer investigator outpatient clinic . All enrolled case ask receive randomly SurePath® conventional smear . Expected Results : The investigator get incidence unsatisfactory smear accuracy detect cervicovaginal lesion SurePath® conventional smear patient underwent radiotherapy .</brief_summary>
	<brief_title>Comparing Rate Insufficient Cells Diagnosis Between Surepath® Conventional Smear Women After Radiation Therapy Cervical Cancer</brief_title>
	<detailed_description>Adequate specimen ( specimen adequacy ) cervical vaginal cytology single important quality factor . 2001 Pap Bethesda System classification maintain previous version , Pap specimen divide satisfactory assessment unsatisfactory evaluation two kind ; meet `` satisfactory assessment `` specimen standard , conventional Pap ( conventional smear ) require least 8,000-12,000-readable squamous cell , liquid-based Pap ( liquid-based smear ) need least 5,000-readable squamous cell . For squamous cell sample determine adequate , yet record specimens intrauterine neck squamous transitional zone ( transformation zone ) border zone cell exist ; quality indicator `` Cell interpretation part inflammation blood mask noise `` specimen , sentence 50-75 % epithelial cell still classify read '' satisfy `` specimen , 75 % epithelial cell obscure interference specimen classify '' unsatisfactory `` specimen .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1 . All woman receive radiotherapy cervical cancer outpatient clinic . 2 . Prior join test subject 90 day earlier receive complete pelvic radiation therapy , include treatment cervix vagina . 3 . Subjects radiation therapy ( include combine chemical radiation therapy postoperative adjuvant [ chemical ] radiation therapy ) first treatment . 1. recurrence cervical cancer 2. hormone treatment within 90 day 3. vaginal vault cervix topical treatment within 90 day . 4 . Subjects malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>